New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer

<table>Therapeutic approaches to block the AR. EPI-001 interacts with the AR NTD to block AR transcriptional activity through this domain. Inhibitors of the LBD include androgen ablation and antiandrogens, DHT, and dihydrotestosterone.</table>

Prostate Cancer

fig2

Figure 2

Figure 2: New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer 